NCT05357755: An ongoing trial by Janssen Research & Development, LLC
This trial is completed, but has been granted a delay in reporting its results.
It must report results 3 months, 1 week from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05357755 |
|---|---|
| Title | A Phase 2a Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Oral Tablet Formulation of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 13, 2022 |
| Completion date | March 23, 2023 |
| Required reporting date | March 23, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |